A Phase I, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of N-acetylgalactosamine Small Interfering RNA Conjugate, BPR-30221616, in Healthy Participants, for Potential Treatment of Transthyretin Amyloidosis

BPR-30221616 - Chengdu Brilliant Pharma

Xiaohong Han1; Rui Chen1; XIWEN CHENG2; langxi zhang2; haoxi huang2; shengjun fan2

Oct 6, 2025